Reduction of syndecan-1 expression is associated with dysplastic oral epithelium

被引:42
作者
Soukka, T
Pohjola, J
Inki, P
Happonen, RP
机构
[1] Univ Turku, Inst Dent, Dept Oral & Maxillofacial Surg, FIN-20520 Turku, Finland
[2] Univ Turku, Cent Hosp, Ctr Biotechnol, FIN-20520 Turku, Finland
[3] Univ Turku, Cent Hosp, Dept Obstet & Gynecol, FIN-20520 Turku, Finland
关键词
dysplasia; malignant transformation; mouth; squamous cell carcinoma; syndecan;
D O I
10.1034/j.1600-0714.2000.290704.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Syndecans are a family of integral membrane proteoglycans that participate in cell-matrix interactions and growth factor binding. Syndecan-1 expression is induced during keratinocyte differentiation and reduced in squamous cell carcinomas. The purpose of this study was to examine the alteration in syndecan-1 expression in dysplastic oral epithelium. Sixty-six oral biopsy specimens (43 epithelial dysplasias, 3 carcinoma in situ and 20 squamous cell carcinomas) were studied using immunohistochemical methods. The normal epithelium specimens were highly positive for syndecan-1. Fifteen of 46 dysplasias or carcinoma in situ specimens showed negative or weak staining for syndecan-1, two of which were totally negative. intermediate and strong staining were observed in 17 and 14 dysplasias or carcinoma in situ specimens, respectively. Thirteen (65%) squamous cell carcinomas showed negative or weak staining for syndecan-1, seven of which were totally negative. Only three carcinomas had a strong syndecan-1 expression. Four of the 34 patients with dysplasia who were followed up developed squamous cell carcinoma. All these dysplasias had weak or totally negative syndecan-1 expression. The results suggest that the loss of syndecan-1 is associated with dysplastic changes in oral epithelium.
引用
收藏
页码:308 / 313
页数:6
相关论文
共 29 条
[1]   INTRAEXAMINER AND INTEREXAMINER RELIABILITY IN THE DIAGNOSIS OF ORAL EPITHELIAL DYSPLASIA [J].
ABBEY, LM ;
KAUGARS, GE ;
GUNSOLLEY, JC ;
BURNS, JC ;
PAGE, DG ;
SVIRSKY, JA ;
EISENBERG, E ;
KRUTCHKOFF, DJ ;
CUSHING, M .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1995, 80 (02) :188-191
[3]  
BURKHARDT A, 1978, DTSCH Z MUND KIEFER, V2, P221
[4]   INDUCED EXPRESSION OF SYNDECAN IN HEALING WOUNDS [J].
ELENIUS, K ;
VAINIO, S ;
LAATO, M ;
SALMIVIRTA, M ;
THESLEFF, I ;
JALKANEN, M .
JOURNAL OF CELL BIOLOGY, 1991, 114 (03) :585-595
[5]   IMMUNOCYTOCHEMISTRY OF CELL-SURFACE HEPARAN-SULFATE PROTEOGLYCAN IN MOUSE-TISSUES - A LIGHT AND ELECTRON-MICROSCOPIC STUDY [J].
HAYASHI, K ;
HAYASHI, M ;
JALKANEN, M ;
FIRESTONE, JH ;
TRELSTAD, RL ;
BERNFIELD, M .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1987, 35 (10) :1079-1088
[6]   ORAL LEUKOPLAKIA, WITH EMPHASIS ON MALIGNANT TRANSFORMATION - A FOLLOW-UP-STUDY OF 46 PATIENTS [J].
HOGEWIND, WFC ;
VANDERKWAST, WAM ;
VANDERWAAL, I .
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 1989, 17 (03) :128-133
[7]   ASSOCIATION BETWEEN SYNDECAN-1 EXPRESSION AND CLINICAL OUTCOME IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
INKI, P ;
JOENSUU, H ;
GRENMAN, R ;
KLEMI, P ;
JALKANEN, M .
BRITISH JOURNAL OF CANCER, 1994, 70 (02) :319-323
[8]  
INKI P, 1991, AM J PATHOL, V139, P1333
[9]  
INKI P, 1992, LAB INVEST, V66, P314
[10]  
INKI P, 1994, EUR J CELL BIOL, V63, P43